Cornelis Verhoef

Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma.

Isolated hepatic perfusion: experimental evidence and clinical utility.

Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.

Relaparotomy following complications of feeding jejunostomy in esophageal surgery.

Preoperative radiotherapy improves outcome in recurrent rectal cancer.

Salvage abdominoperineal resection and perineal wound healing in local recurrent or persistent anal cancer.

Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.

Value of intraoperative radiotherapy in locally advanced rectal cancer.

Pelvic exenteration for primary and recurrent gynaecological malignancies.

Giant solitary fibrous tumour of the liver.

Giant myositis ossificans of the leg.

Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors.

Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.

Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.

Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients.

Glomus tumor of the mesentery with atypical features: a case report.

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Detection of melanoma micrometastases in sentinel nodes - the cons.

Isolated hepatic perfusion for the treatment of liver tumors: sunset or sunrise?

The Rotterdam criteria for sentinel node tumor load: the simplest prognostic factor?

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.

Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy.

Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities.

The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases.

Stereotactic body radiation therapy for liver tumors: impact of daily setup corrections and day-to-day anatomic variations on dose in target and organs at risk.

[Improvement of 5 year survival rate after liver resection for colorectal metastases between 1984-2006].

On the origin of (CD105+) circulating endothelial cells.

Radiofrequency ablation in the treatment of hepatocellular carcinoma: the need for centralization.

Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up.

Management of locally advanced primary and recurrent rectal cancer.

New developments in sentinel node staging in melanoma: controversies and alternatives.

Circulating tumor cells and sample size: the more, the better.

Trends in treatment for synchronous colorectal liver metastases: differences in outcome before and after 2000.

Importance of tumor load in the sentinel node in melanoma: clinical dilemmas.

EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.

[Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].

Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors.

Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?

Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.

Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?

Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases.

Surgical treatment of renal cell cancer liver metastases: a population-based study.

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site.

Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?

Local and intralesional therapy of in-transit melanoma metastases.

Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.

20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters.

Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.

Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients.

Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.

Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.

Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989.

Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI.

Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against.

Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases.

Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?

Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial.

Surgical management of rectal gastrointestinal stromal tumors.

Is bone scintigraphy indicated in surgical work-up for hepatocellular carcinoma patients?

Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary?

Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer.

Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer.

Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.

Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase.

Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors.

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.

Completion lymph node dissection after a positive sentinel node: no longer a must?

Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases.

Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis.

Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.

Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.

Collagen peptides in urine: a new promising biomarker for the detection of colorectal liver metastases.

Prognosis of solitary fibrous tumors: a multicenter study.

The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.

Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.

MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy.

Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.

Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy.

Intraoperative radiation therapy reduces local recurrence rates in patients with microscopically involved circumferential resection margins after resection of locally advanced rectal cancer.

Prophylactic nipple-sparing mastectomy leaves more terminal duct lobular units in situ as compared with skin-sparing mastectomy.

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.

Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma.

Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.

The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).

Preoperative prediction of cosmetic results in breast conserving surgery.

Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.

Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas.

Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohort.

Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials.

Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.

The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.

A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities.

[The treatment of locally recurrent rectal cancer].

Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).

Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy.

Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study.

Patient Satisfaction and Nipple-Areola Sensitivity After Bilateral Prophylactic Mastectomy and Immediate Implant Breast Reconstruction in a High Breast Cancer Risk Population: Nipple-Sparing Mastectomy Versus Skin-Sparing Mastectomy.

Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.

Transanal minimally invasive surgery: impact on quality of life and functional outcome.

Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors.

The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.

Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.

GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo.

Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.

Abdominal Desmoid Tumors: Hands Off?

Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection.

Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases.

Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.

Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis.